Our mission is to transform cardiovascular care through genomic discovery and precision medicine implementation.
We harness the power of large-scale biobank data and advanced genomic analyses to uncover the genetic basis of cardiovascular diseases. Our work spans from initial discovery to clinical implementation, with a particular focus on atherosclerotic diseases, aortic conditions, and heart failure.
Through collaboration with the Million Veteran Program, Penn Medicine Biobank, and other major cohorts, we're identifying novel genetic variants that affect disease susceptiblity, which we use to develop new therapeutic targets and personalized prevention and treatment strategies that account for each individual's genetic risk profile.
70+ peer-reviewed publications
10+ trainees mentored
3 active grant-funded projects
IL-6 pathway advanced to clinical trials for PAD
Leading multi-center genomic studies
Novel therapeutic targets identified in AAA
We leverage large-scale genetic association studies using biobank data to identify cardiovascular disease risk factors and therapeutic targets.
Our work spans the full spectrum of cardiovascular diseases, including:
Implementation of genetic discoveries into clinical practice:
Unraveling the Genetic Basis and Cardiovascular Impact of Lipoprotein(a) in Diverse Populations
2024-2029
Genetically Informed Targeting of Interleukin-6 Signaling to Treat Peripheral Artery Disease
2023-2025
University of Pennsylvania
MS in Translational Research
2021-Present
Hospital of the University of Pennsylvania
Cardiovascular Medicine Fellowship
2019-2023
Hospital of the University of Pennsylvania
Internal Medicine Residency
2016-2019
Rutgers New Jersey Medical School
MD
2012-2016
University of Pennsylvania
BA
2007-2011
University of Pennsylvania Perelman School of Medicine
Division of Cardiovascular Medicine
3400 Civic Center Blvd.
Smilow 11-133
Philadelphia, PA 19104
Hospital of the University of Pennsylvania
Corporal Michael J. Crescenz VA Medical Center